Trials / Suspended
SuspendedNCT01050725
Pilot Study of Biomarkers for Radiation Therapy
Investigating Proteomic Biomarkers of Radiation Therapy Outcome: A Pilot Study
- Status
- Suspended
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Benaroya Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether specific assays of DNA damage repair proteins can be used in patients undergoing radiation therapy. The ultimate goal of this research is to develop clinically useful biomarkers from blood samples that could be used to customize radiation treatment for individuals, leading to reduced side effects and improved outcomes.
Conditions
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2013-06-01
- First posted
- 2010-01-15
- Last updated
- 2011-06-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01050725. Inclusion in this directory is not an endorsement.